We are live on ! Find out more
LPCN icon

Lipocine
LPCN

58 hedge funds and large institutions have $30.3M invested in Lipocine in 2016 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 16 increasing their positions, 12 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

367% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 3

33% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 12

23% more funds holding

Funds holding: 47 → 58 (+11)

2.65% more ownership

Funds ownership: 0% → 2.65% (+2.7%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

17% less capital invested

Capital invested by funds: $36.5M → $30.3M (-$6.18M)

Holders
58
Holders Change
+11
Holders Change %
+23.4%
% of All Funds
1.45%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
14
Increased
16
Reduced
12
Closed
3
Calls
$160K
Puts
–
Net Calls
+$160K
Net Calls Change
+$216K

Top Buyers

1
Millennium Management
Millennium Management
New York
+$697K
2
CC
Carlson Capital
Texas
+$684K
3
BFA
BlackRock Fund Advisors
California
+$270K
4
Morgan Stanley
Morgan Stanley
New York
+$192K
5
RA
Royce & Associates
New York
+$179K

Top Sellers

1
FCMI
Foresite Capital Management III
California
-$1.35M
2
Vanguard Group
Vanguard Group
Pennsylvania
-$863K
3
DS
DRW Securities
Illinois
-$651K
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$112K
5
EEG
E.E. Geduld
-$55.9K
Name Holding Trade Value Shares
Change 		Change in
Stake
RA
1
Royce & Associates
New York
$4.34M +$179K +2,830 +4%
Invesco
2
Invesco
Georgia
$3.96M +$3.29K +52 +0.1%
VM
3
VHCP Management
New York
$3.13M – – –
CAM
4
Cormorant Asset Management
Massachusetts
$2.77M – – –
CC
5
Carlson Capital
Texas
$2.22M +$684K +10,800 +44%
BFA
6
BlackRock Fund Advisors
California
$1.98M +$270K +4,265 +16%
VMI
7
VHCP Management II
New York
$1.55M – – –
Vanguard Group
8
Vanguard Group
Pennsylvania
$1.38M -$863K -13,639 -38%
BIT
9
BlackRock Institutional Trust
California
$1.35M – – –
Dimensional Fund Advisors
10
Dimensional Fund Advisors
Texas
$954K -$112K -1,777 -10%
State Street
11
State Street
Massachusetts
$867K +$4.68K +74 +0.5%
JP Morgan Chase
12
JP Morgan Chase
New York
$756K -$15.6K -247 -2%
Millennium Management
13
Millennium Management
New York
$689K +$697K +11,012 New
Northern Trust
14
Northern Trust
Illinois
$669K -$3.42K -54 -0.5%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$416K +$13K +206 +3%
Bank of New York Mellon
16
Bank of New York Mellon
New York
$319K +$124K +1,962 +62%
Federated Hermes
17
Federated Hermes
Pennsylvania
$301K +$380 +6 +0.1%
Ameriprise
18
Ameriprise
Minnesota
$243K -$3.73K -59 -1%
BIM
19
BlackRock Investment Management
Delaware
$230K – – –
Morgan Stanley
20
Morgan Stanley
New York
$211K +$192K +3,040 +899%
TCIM
21
TIAA CREF Investment Management
New York
$196K -$4.43K -70 -2%
PPA
22
Parametric Portfolio Associates
Washington
$170K +$26.1K +413 +18%
California Public Employees Retirement System
23
California Public Employees Retirement System
California
$169K – – –
California State Teachers Retirement System (CalSTRS)
24
California State Teachers Retirement System (CalSTRS)
California
$127K – – –
TA
25
Teachers Advisors
New York
$121K +$25.6K +404 +26%
1
2 3

LPCN Hedge Fund Activity: Q4 2016 in Review

58 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Lipocine (LPCN) for Q4 2016, worth a combined $30.3M — down 17% from $36.5M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new LPCN positions and 3 closed out — a net gain of 11 holders — while 16 added to existing stakes and 12 trimmed.

The largest buyer was Millennium Management, opening a new position worth an estimated $697K. The largest seller was Foresite Capital Management III, exiting entirely with an estimated $1.35M sold.

  • 58 institutional investors held Lipocine (LPCN) as of Q4 2016, up from 47 in Q3 2016.
  • Funds reported $30.3M of Lipocine stock for Q4 2016, down 17% quarter-over-quarter.
  • 14 funds opened new Lipocine positions in Q4 2016 and 3 closed out, a net change of +11 holders.
  • The largest Lipocine buyer in Q4 2016 was Millennium Management, an estimated $697K added.
  • The largest Lipocine seller in Q4 2016 was Foresite Capital Management III, an estimated $1.35M sold.

Based on aggregated 13F filings for Q4 2016.